Which has better earnings & valuation, SPNT or HIPO?

SiriusPoint has higher revenue and earnings than Hippo. SiriusPoint is trading at a lower price-to-earnings ratio than Hippo, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio SiriusPoint $3.21B 0.90 $459.60M $4.02 6.13 Hippo $468.60M 0.06 $57.70M $4.32 6.68

Is SPNT or HIPO more profitable?

Hippo has a net margin of 23.45% compared to SiriusPoint's net margin of 15.38%. SiriusPoint's return on equity of 16.92% beat Hippo's return on equity. Company Net Margins Return on Equity Return on Assets SiriusPoint 15.38% 16.92% 2.88% Hippo 23.45% 12.17% 2.64%

Does the media favor HIPO or CLOV?

In the previous week, Hippo had 3 more articles in the media than Clover Health Investments. MarketBeat recorded 10 mentions for Hippo and 7 mentions for Clover Health Investments. Clover Health Investments' average media sentiment score of 0.41 beat Hippo's score of 0.11 indicating that Clover Health Investments is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Hippo 0 Very Positive mention(s) 1 Positive mention(s) 5 Neutral mention(s) 2 Negative mention(s) 1 Very Negative mention(s) Neutral Clover Health Investments 1 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral

Does the media refer more to SKWD or HIPO?

In the previous week, Skyward Specialty Insurance Group and Skyward Specialty Insurance Group both had 10 articles in the media. Skyward Specialty Insurance Group's average media sentiment score of 0.54 beat Hippo's score of 0.11 indicating that Skyward Specialty Insurance Group is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Skyward Specialty Insurance Group 3 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Positive Hippo 0 Very Positive mention(s) 1 Positive mention(s) 5 Neutral mention(s) 2 Negative mention(s) 1 Very Negative mention(s) Neutral

Which has stronger valuation & earnings, HIPO or FIHL?

Fidelis Insurance has higher revenue and earnings than Hippo. Hippo is trading at a lower price-to-earnings ratio than Fidelis Insurance, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Hippo $468.60M 0.06 $57.70M $4.32 6.68 Fidelis Insurance $2.17B 1.11 $225.50M $2.21 11.31

Which has preferable valuation & earnings, SLDE or HIPO?

Slide Insurance has higher revenue and earnings than Hippo. Slide Insurance is trading at a lower price-to-earnings ratio than Hippo, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Slide Insurance $1.16B 2.11 $443.96M $3.60 5.90 Hippo $468.60M 0.06 $57.70M $4.32 6.68

Is SLDE or HIPO more profitable?

Slide Insurance has a net margin of 38.86% compared to Hippo's net margin of 23.45%. Slide Insurance's return on equity of 48.38% beat Hippo's return on equity. Company Net Margins Return on Equity Return on Assets Slide Insurance 38.86% 48.38% 17.38% Hippo 23.45% 12.17% 2.64%

Does the media prefer SLDE or HIPO?

In the previous week, Slide Insurance had 1 more articles in the media than Hippo. MarketBeat recorded 11 mentions for Slide Insurance and 10 mentions for Hippo. Slide Insurance's average media sentiment score of 0.24 beat Hippo's score of 0.11 indicating that Slide Insurance is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Slide Insurance 2 Very Positive mention(s) 2 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Hippo 0 Very Positive mention(s) 1 Positive mention(s) 5 Neutral mention(s) 2 Negative mention(s) 1 Very Negative mention(s) Neutral

Hippo (HIPO) Competitors

$28.84 -0.07 (-0.23%)

Closing price 07/10/2026 03:59 PM Eastern

Extended Trading

$28.70 -0.14 (-0.50%)

As of 07/10/2026 04:10 PM Eastern

Compare

HIPO vs. SPNT, CLOV, SKWD, FIHL, and SLDE

Should you buy Hippo stock or one of its competitors? MarketBeat compares Hippo with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Hippo include SiriusPoint (SPNT), Clover Health Investments (CLOV), Skyward Specialty Insurance Group (SKWD), Fidelis Insurance (FIHL), and Slide Insurance (SLDE). These companies are all part of the "insurance" industry.

How does Hippo compare to SiriusPoint?

SiriusPoint (NYSE:SPNT) and Hippo (NYSE:HIPO) are both finance companies, but which is the superior stock? We will contrast the two businesses based on the strength of their institutional ownership, media sentiment, earnings, risk, analyst recommendations, profitability, dividends and valuation.

Hippo has a net margin of 23.45% compared to SiriusPoint's net margin of 15.38%. SiriusPoint's return on equity of 16.92% beat Hippo's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
SiriusPoint	15.38%	16.92%	2.88%
Hippo	23.45%	12.17%	2.64%

52.8% of SiriusPoint shares are owned by institutional investors. Comparatively, 43.0% of Hippo shares are owned by institutional investors. 12.2% of SiriusPoint shares are owned by company insiders. Comparatively, 10.8% of Hippo shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

SiriusPoint has higher revenue and earnings than Hippo. SiriusPoint is trading at a lower price-to-earnings ratio than Hippo, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
SiriusPoint	$3.21B	0.90	$459.60M	$4.02	6.13
Hippo	$468.60M	0.06	$57.70M	$4.32	6.68

SiriusPoint has a beta of 0.6, suggesting that its stock price is 40% less volatile than the broader market. Comparatively, Hippo has a beta of 1.49, suggesting that its stock price is 49% more volatile than the broader market.

SiriusPoint currently has a consensus price target of $31.00, suggesting a potential upside of 25.84%. Hippo has a consensus price target of $38.67, suggesting a potential upside of 34.05%. Given Hippo's stronger consensus rating and higher probable upside, analysts clearly believe Hippo is more favorable than SiriusPoint.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
SiriusPoint	0 Sell rating(s)	3 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.40
Hippo	0 Sell rating(s)	3 Hold rating(s)	3 Buy rating(s)	1 Strong Buy rating(s)	2.71

In the previous week, Hippo had 10 more articles in the media than SiriusPoint. MarketBeat recorded 10 mentions for Hippo and 0 mentions for SiriusPoint. SiriusPoint's average media sentiment score of 1.00 beat Hippo's score of 0.11 indicating that SiriusPoint is being referred to more favorably in the media.

Company	Overall Sentiment
SiriusPoint	Positive
Hippo	Neutral

Summary

Hippo beats SiriusPoint on 9 of the 17 factors compared between the two stocks.

How does Hippo compare to Clover Health Investments?

Hippo (NYSE:HIPO) and Clover Health Investments (NASDAQ:CLOV) are both insurance companies, but which is the better stock? We will contrast the two businesses based on the strength of their media sentiment, dividends, profitability, risk, analyst recommendations, valuation, earnings and institutional ownership.

Hippo has a net margin of 23.45% compared to Clover Health Investments' net margin of -2.58%. Hippo's return on equity of 12.17% beat Clover Health Investments' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Hippo	23.45%	12.17%	2.64%
Clover Health Investments	-2.58%	-16.52%	-9.28%

Hippo has a beta of 1.49, suggesting that its share price is 49% more volatile than the broader market. Comparatively, Clover Health Investments has a beta of 2.41, suggesting that its share price is 141% more volatile than the broader market.

43.0% of Hippo shares are held by institutional investors. Comparatively, 19.8% of Clover Health Investments shares are held by institutional investors. 10.8% of Hippo shares are held by company insiders. Comparatively, 23.5% of Clover Health Investments shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Hippo currently has a consensus target price of $38.67, suggesting a potential upside of 34.05%. Clover Health Investments has a consensus target price of $3.82, suggesting a potential downside of 14.04%. Given Hippo's stronger consensus rating and higher probable upside, equities research analysts plainly believe Hippo is more favorable than Clover Health Investments.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Hippo	0 Sell rating(s)	3 Hold rating(s)	3 Buy rating(s)	1 Strong Buy rating(s)	2.71
Clover Health Investments	1 Sell rating(s)	3 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

Hippo has higher earnings, but lower revenue than Clover Health Investments. Clover Health Investments is trading at a lower price-to-earnings ratio than Hippo, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Hippo	$468.60M	0.06	$57.70M	$4.32	6.68
Clover Health Investments	$1.92B	1.22	-$85.55M	-$0.12	N/A

In the previous week, Hippo had 3 more articles in the media than Clover Health Investments. MarketBeat recorded 10 mentions for Hippo and 7 mentions for Clover Health Investments. Clover Health Investments' average media sentiment score of 0.41 beat Hippo's score of 0.11 indicating that Clover Health Investments is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Hippo	0 Very Positive mention(s)	1 Positive mention(s)	5 Neutral mention(s)	2 Negative mention(s)	1 Very Negative mention(s)	Neutral
Clover Health Investments	1 Very Positive mention(s)	1 Positive mention(s)	3 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral

Summary

Hippo beats Clover Health Investments on 12 of the 17 factors compared between the two stocks.

How does Hippo compare to Skyward Specialty Insurance Group?

Skyward Specialty Insurance Group (NASDAQ:SKWD) and Hippo (NYSE:HIPO) are both finance companies, but which is the superior business? We will compare the two companies based on the strength of their profitability, media sentiment, analyst recommendations, institutional ownership, risk, earnings, valuation and dividends.

In the previous week, Skyward Specialty Insurance Group and Skyward Specialty Insurance Group both had 10 articles in the media. Skyward Specialty Insurance Group's average media sentiment score of 0.54 beat Hippo's score of 0.11 indicating that Skyward Specialty Insurance Group is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Skyward Specialty Insurance Group	3 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	1 Very Negative mention(s)	Positive
Hippo	0 Very Positive mention(s)	1 Positive mention(s)	5 Neutral mention(s)	2 Negative mention(s)	1 Very Negative mention(s)	Neutral

Skyward Specialty Insurance Group currently has a consensus target price of $67.22, suggesting a potential upside of 13.28%. Hippo has a consensus target price of $38.67, suggesting a potential upside of 34.05%. Given Hippo's higher possible upside, analysts plainly believe Hippo is more favorable than Skyward Specialty Insurance Group.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Skyward Specialty Insurance Group	0 Sell rating(s)	2 Hold rating(s)	8 Buy rating(s)	1 Strong Buy rating(s)	2.91
Hippo	0 Sell rating(s)	3 Hold rating(s)	3 Buy rating(s)	1 Strong Buy rating(s)	2.71

Hippo has a net margin of 23.45% compared to Skyward Specialty Insurance Group's net margin of 11.36%. Skyward Specialty Insurance Group's return on equity of 18.24% beat Hippo's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Skyward Specialty Insurance Group	11.36%	18.24%	3.69%
Hippo	23.45%	12.17%	2.64%

Skyward Specialty Insurance Group has a beta of 0.34, indicating that its stock price is 66% less volatile than the broader market. Comparatively, Hippo has a beta of 1.49, indicating that its stock price is 49% more volatile than the broader market.

Skyward Specialty Insurance Group has higher revenue and earnings than Hippo. Hippo is trading at a lower price-to-earnings ratio than Skyward Specialty Insurance Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Skyward Specialty Insurance Group	$1.42B	1.70	$170.03M	$4.15	14.30
Hippo	$468.60M	0.06	$57.70M	$4.32	6.68

94.8% of Skyward Specialty Insurance Group shares are held by institutional investors. Comparatively, 43.0% of Hippo shares are held by institutional investors. 8.5% of Skyward Specialty Insurance Group shares are held by insiders. Comparatively, 10.8% of Hippo shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Summary

Skyward Specialty Insurance Group beats Hippo on 10 of the 15 factors compared between the two stocks.

How does Hippo compare to Fidelis Insurance?

Hippo (NYSE:HIPO) and Fidelis Insurance (NYSE:FIHL) are both finance companies, but which is the better stock? We will contrast the two companies based on the strength of their valuation, risk, earnings, institutional ownership, media sentiment, profitability, dividends and analyst recommendations.

Hippo has a beta of 1.49, meaning that its share price is 49% more volatile than the broader market. Comparatively, Fidelis Insurance has a beta of 0.36, meaning that its share price is 64% less volatile than the broader market.

Fidelis Insurance has higher revenue and earnings than Hippo. Hippo is trading at a lower price-to-earnings ratio than Fidelis Insurance, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Hippo	$468.60M	0.06	$57.70M	$4.32	6.68
Fidelis Insurance	$2.17B	1.11	$225.50M	$2.21	11.31

43.0% of Hippo shares are owned by institutional investors. Comparatively, 82.0% of Fidelis Insurance shares are owned by institutional investors. 10.8% of Hippo shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

In the previous week, Hippo had 10 more articles in the media than Fidelis Insurance. MarketBeat recorded 10 mentions for Hippo and 0 mentions for Fidelis Insurance. Hippo's average media sentiment score of 0.11 beat Fidelis Insurance's score of -0.54 indicating that Hippo is being referred to more favorably in the media.

Company	Overall Sentiment
Hippo	Neutral
Fidelis Insurance	Negative

Hippo has a net margin of 23.45% compared to Fidelis Insurance's net margin of 9.02%. Hippo's return on equity of 12.17% beat Fidelis Insurance's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Hippo	23.45%	12.17%	2.64%
Fidelis Insurance	9.02%	8.62%	1.62%

Hippo presently has a consensus price target of $38.67, indicating a potential upside of 34.05%. Fidelis Insurance has a consensus price target of $21.92, indicating a potential downside of 12.30%. Given Hippo's stronger consensus rating and higher possible upside, equities research analysts plainly believe Hippo is more favorable than Fidelis Insurance.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Hippo	0 Sell rating(s)	3 Hold rating(s)	3 Buy rating(s)	1 Strong Buy rating(s)	2.71
Fidelis Insurance	2 Sell rating(s)	3 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.13

Summary

Hippo beats Fidelis Insurance on 11 of the 16 factors compared between the two stocks.

How does Hippo compare to Slide Insurance?

Slide Insurance (NASDAQ:SLDE) and Hippo (NYSE:HIPO) are both insurance companies, but which is the better business? We will compare the two companies based on the strength of their institutional ownership, analyst recommendations, profitability, media sentiment, risk, valuation, dividends and earnings.

Slide Insurance has a net margin of 38.86% compared to Hippo's net margin of 23.45%. Slide Insurance's return on equity of 48.38% beat Hippo's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Slide Insurance	38.86%	48.38%	17.38%
Hippo	23.45%	12.17%	2.64%

Slide Insurance has higher revenue and earnings than Hippo. Slide Insurance is trading at a lower price-to-earnings ratio than Hippo, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Slide Insurance	$1.16B	2.11	$443.96M	$3.60	5.90
Hippo	$468.60M	0.06	$57.70M	$4.32	6.68

Slide Insurance currently has a consensus price target of $24.00, suggesting a potential upside of 12.99%. Hippo has a consensus price target of $38.67, suggesting a potential upside of 34.05%. Given Hippo's higher probable upside, analysts clearly believe Hippo is more favorable than Slide Insurance.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Slide Insurance	0 Sell rating(s)	3 Hold rating(s)	5 Buy rating(s)	1 Strong Buy rating(s)	2.78
Hippo	0 Sell rating(s)	3 Hold rating(s)	3 Buy rating(s)	1 Strong Buy rating(s)	2.71

43.0% of Hippo shares are held by institutional investors. 50.8% of Slide Insurance shares are held by company insiders. Comparatively, 10.8% of Hippo shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

In the previous week, Slide Insurance had 1 more articles in the media than Hippo. MarketBeat recorded 11 mentions for Slide Insurance and 10 mentions for Hippo. Slide Insurance's average media sentiment score of 0.24 beat Hippo's score of 0.11 indicating that Slide Insurance is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Slide Insurance	2 Very Positive mention(s)	2 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Hippo	0 Very Positive mention(s)	1 Positive mention(s)	5 Neutral mention(s)	2 Negative mention(s)	1 Very Negative mention(s)	Neutral

Summary

Slide Insurance beats Hippo on 11 of the 15 factors compared between the two stocks.

Get Hippo News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding HIPO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

HIPO vs. The Competition

Export

Metric	Hippo	INS Industry	Finance Sector	NYSE Exchange
Market Cap	$30.11M	$21.97B	$14.19B	$23.43B
Dividend Yield	N/A	3.27%	5.71%	4.04%
P/E Ratio	6.68	11.45	20.49	31.27
Price / Sales	0.06	1.78	44.78	20.39
Price / Cash	83.48	13.30	19.30	25.05
Price / Book	1.70	2.76	2.26	4.77
Net Income	$57.70M	$1.89B	$1.14B	$1.07B
7 Day Performance	-0.38%	-0.38%	0.21%	-0.50%
1 Month Performance	13.56%	6.10%	1.63%	2.09%
1 Year Performance	10.56%	5.69%	12.10%	16.03%

Hippo Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
HIPO Hippo	4.3867 of 5 stars	$28.84 -0.2%	$38.67 +34.1%	+4.9%	$30.11M	$468.60M	6.68	620	Analyst Forecast
SPNT SiriusPoint	3.8171 of 5 stars	$24.12 +0.6%	$31.00 +28.5%	+33.5%	$2.84B	$3.22B	6.00	1,099	Positive News
CLOV Clover Health Investments	1.55 of 5 stars	$5.23 -1.6%	$3.82 -27.0%	+45.6%	$2.76B	$1.92B	N/A	680
SKWD Skyward Specialty Insurance Group	4.0929 of 5 stars	$60.20 +0.0%	$65.00 +8.0%	+11.1%	$2.44B	$1.42B	14.51	400	Analyst Forecast
FIHL Fidelis Insurance	1.941 of 5 stars	$24.78 +0.2%	$21.92 -11.6%	+56.9%	$2.40B	$2.17B	11.21	77

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:HIPO) was last updated on 7/11/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Hippo (HIPO) Competitors

HIPO vs. SPNT, CLOV, SKWD, FIHL, and SLDE

How does Hippo compare to SiriusPoint?

Summary

How does Hippo compare to Clover Health Investments?

Summary

How does Hippo compare to Skyward Specialty Insurance Group?

Summary

How does Hippo compare to Fidelis Insurance?

Summary

How does Hippo compare to Slide Insurance?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

HIPO vs. The Competition

Hippo Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Hippo (HIPO) Competitors

HIPO vs. SPNT, CLOV, SKWD, FIHL, and SLDE

How does Hippo compare to SiriusPoint?

Is SPNT or HIPO more profitable?

Do institutionals & insiders hold more shares of SPNT or HIPO?

Which has better earnings & valuation, SPNT or HIPO?

Which has more volatility & risk, SPNT or HIPO?

Do analysts rate SPNT or HIPO?

Does the media prefer SPNT or HIPO?

Summary

How does Hippo compare to Clover Health Investments?

Is HIPO or CLOV more profitable?

Which has more volatility and risk, HIPO or CLOV?

Do insiders & institutionals hold more shares of HIPO or CLOV?

Do analysts prefer HIPO or CLOV?

Which has better earnings and valuation, HIPO or CLOV?

Does the media favor HIPO or CLOV?

Summary

How does Hippo compare to Skyward Specialty Insurance Group?

Does the media refer more to SKWD or HIPO?

Do analysts recommend SKWD or HIPO?

Is SKWD or HIPO more profitable?

Which has more risk & volatility, SKWD or HIPO?

Which has better valuation & earnings, SKWD or HIPO?

Do insiders & institutionals have more ownership in SKWD or HIPO?

Summary

How does Hippo compare to Fidelis Insurance?

Which has more risk and volatility, HIPO or FIHL?

Which has stronger valuation & earnings, HIPO or FIHL?

Do insiders and institutionals have more ownership in HIPO or FIHL?

Does the media refer more to HIPO or FIHL?

Is HIPO or FIHL more profitable?

Do analysts recommend HIPO or FIHL?

Summary

How does Hippo compare to Slide Insurance?

Is SLDE or HIPO more profitable?

Which has preferable valuation & earnings, SLDE or HIPO?

Do analysts rate SLDE or HIPO?

Do insiders & institutionals hold more shares of SLDE or HIPO?

Does the media prefer SLDE or HIPO?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

HIPO vs. The Competition

Hippo Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools